Clinical determinants of arterial stiffness by cardio-ankle vascular index measurement in patients with type 2 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210323003

Enrollment

585

Registered

2021-03-23

Start date

2020-09-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes and non diabetes Type 2 diabetes, Cardio-ankle vascular index (CAVI), Arterial stiffness

Interventions

plasma glucose greater than or equal to 126 mg known case of diabetes,Those without diabetes

Screening,Screening

Diabetes,Non-diabetes

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: male or female sex, at least 18 years of age, previously underwent cardiovascular risk and general health assessment

Exclusion criteria

Exclusion criteria: pregnant women, chronically infected with human immunodeficiency virus (HIV), chronic hepatitis B or C infection, malignancy with active treatment, currently on medication that might affect arterial stiffness assessment such as pseudoephedrine or ephedrine

Design outcomes

Primary

Measure	Time frame
Cardio-ankle vascular index Baseline Unit	—

Secondary

Measure	Time frame
Common carotid artery intima-media thickness Baseline millimeter,Ankle-brachial index baseline Unit	—

Countries

Thailand

Contacts

Public ContactThep Chalermchai

Mae Fah Luang University

thep_chalermchai@hotmail.com0815552552

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026